# Italy implements pediatric screening for diabetes and celiac

> Developing situation record from CLSTR: https://clstr.news/situations/diabetes-management-and-screening-in-italy
> Updated: 2026-11-13T16:28:00.000Z. Sources: 30. Developments: 2.

Italy is addressing significant diabetes challenges, with approximately 3.8 million people diagnosed and an estimated 1 million more living with the condition undiagnosed. Most cases involve type 2 diabetes, which is influenced by daily habits such as eating while watching screens.

New therapeutic developments include a favorable opinion from the European Medicines Agency for a weekly combination of basal insulin icodec and semaglutide. This formulation aims to improve glycemic control and reduce treatment complexity.

Following the enactment of Law 130 of 2023, Italy has established a national pediatric screening program for type 1 diabetes and celiac disease. During a World Diabetes Day event at the Chamber of Deputies, officials and medical experts noted that this legislation makes Italy a “global pioneer in population-wide pediatric screening.” Health Minister Orazio Schillaci and Deputy Speaker Giorgio Mulè have highlighted the law as a global model for preventive medicine.

The program aims for early diagnosis to prevent ketoacidosis, a severe complication often seen in preschool-aged children. By identifying children with specific antibodies, medical professionals can provide close medical and psychological follow-up, offering a window of several years to manage the condition before full onset.

Pilot projects, such as the PreSchool D1Ce Screen, are being developed to target children aged 3 to 5 using a non-invasive dried blood spot (DBS) method. During recent discussions on World Diabetes Day, medical professionals, including Raffaella Buzzetti of the Italian Society of Diabetology, emphasized that while the law is a major achievement, the next steps require structuring detailed monitoring paths. Experts stress that moving from pilot phases to full national implementation is essential to ensure uniform treatment across all Italian regions and avoid healthcare fragmentation.

## Claims

- Law 130 introduces a pediatric screening program for type 1 diabetes and celiac disease. (reported by 4 sources)
- The operational phase of the screening program is scheduled to begin in April. (reported by 1 source)
- The D1Ce Screen study was conducted as a preparatory study for the screening program. (reported by 1 source)
- Screening results have shown a drastic reduction in ketoacidosis in children at the onset of diabetes. (reported by 1 source)

## Timeline

### 2026-11-13: Italy implements pediatric screening for diabetes and celiac disease

Italy celebrates the impact of Law 130, a pioneering national pediatric screening program for type 1 diabetes and celiac disease, focusing on early diagnosis and regional healthcare uniformity.

26 sources. https://clstr.news/cluster/italy-implements-law-130-for-pediatric-diabetes-and-celiac-disease-screening

### 2026-11-11: Italy faces diabetes challenges amid potential new weekly treatments

Italy reports 3.8 million diabetes cases, with experts highlighting a potential shift toward weekly insulin and semaglutide combinations to simplify treatment and improve patient quality of life.

6 sources. https://clstr.news/cluster/italy-faces-diabetes-challenges-amid-potential-new-weekly-treatments

---
Cite as: Italy implements pediatric screening for diabetes and celiac. CLSTR, https://clstr.news/situations/diabetes-management-and-screening-in-italy
